Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Price to Cash Earnings (PCE)

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023
   PCE(x) 51.24-970.7575.24

What is the latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC ?

The latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC is 51.24 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202551.24
Mar2024-970.75
Mar202375.24

How is Price to Cash Earnings (PCE) of GENPHARMASEC Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 51.24
Positive
Mar2024 -970.75
Negative
Mar2023 75.24 -

Other Financial Ratios of GENPHARMASEC


Compare Price to Cash Earnings (PCE) ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹84.2 Cr 2.7% -14.6% -46.8% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹7,967.6 Cr 1.4% -14.3% 2.5% Stock Analytics
KIRI INDUSTRIES ₹3,532.6 Cr 12.5% 4.7% -0.8% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,794.0 Cr -2.1% 6.6% -25.3% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,298.4 Cr 2% -5.7% 39.8% Stock Analytics
BODAL CHEMICALS ₹682.0 Cr -1.9% -12.6% -25.5% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

2.7%

-14.6%

-46.8%

SENSEX

0.6%

1.3%

7%


You may also like the below Video Courses